The medications in question are Monoprost Duo and Encil Duofree, eye drops containing latanoprost + timolol, which are experiencing supply difficulties due to manufacturing constraints.
Two medications facing supply difficulties
Monday, 16 February 2026RSS
Context & Explainers
Glaucoma is a group of eye conditions that damage the optic nerve, usually associated with raised pressure inside the eye, and can cause irreversible vision loss if untreated. It is a chronic condition managed with pressure‑lowering eye drops, laser therapy, or surgery, so patients should check with their ophthalmologist or pharmacist if prescription substitutions are temporarily allowed.
Ocular hypertension means the pressure inside the eye (intraocular pressure) is higher than normal—typically above about 21 mmHg—without detectable optic nerve damage or visual field loss. It is a risk factor for glaucoma, so doctors usually monitor it regularly and may start treatment to lower pressure if the risk of progression is judged significant.
AI Summary AvailableGlaucoma drugs and ocular-hypertension meds face shortagesRead the synthesized summary with context and explainers
View full article on Observador
